TGFB1 and small cell lung carcinoma: Our previous experimental study has demonstrated a novel miR-886-3p-mediated mechanism underlying the aberrant expression of in polo-like kinase 1 (PLK1) and transforming growth factor beta 1 (TGF-β1) in SCLC [23].